ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 35 filers reported holding ENOCHIAN BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $267,324 | +1653.4% | 59,804 | +122.3% | 0.00% | – |
Q2 2023 | $15,246 | -89.8% | 26,908 | -83.5% | 0.00% | – |
Q1 2023 | $149,667 | -9.9% | 163,553 | +1.4% | 0.00% | – |
Q4 2022 | $166,052 | -38.7% | 161,216 | +7.8% | 0.00% | – |
Q3 2022 | $271,000 | -7.5% | 149,536 | -1.6% | 0.00% | – |
Q2 2022 | $293,000 | +32.0% | 152,008 | +464.9% | 0.00% | – |
Q1 2022 | $222,000 | +13.3% | 26,908 | 0.0% | 0.00% | – |
Q4 2021 | $196,000 | +3.7% | 26,908 | -4.3% | 0.00% | – |
Q3 2021 | $189,000 | +35.0% | 28,103 | 0.0% | 0.00% | – |
Q2 2021 | $140,000 | -73.8% | 28,103 | -81.4% | 0.00% | – |
Q1 2021 | $534,000 | +12.4% | 150,779 | -6.2% | 0.00% | – |
Q4 2020 | $475,000 | -23.5% | 160,762 | -7.2% | 0.00% | – |
Q3 2020 | $621,000 | -2.1% | 173,321 | +15.0% | 0.00% | – |
Q2 2020 | $634,000 | +16.8% | 150,679 | -16.8% | 0.00% | – |
Q1 2020 | $543,000 | -31.9% | 181,136 | +14.1% | 0.00% | – |
Q4 2019 | $797,000 | +193.0% | 158,701 | +220.9% | 0.00% | – |
Q3 2019 | $272,000 | +455.1% | 49,452 | +351.3% | 0.00% | – |
Q2 2019 | $49,000 | – | 10,958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
Ergoteles LLC | 47,984 | $238,000 | 0.01% |
Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
UBS Group AG | 260 | $1,000 | 0.00% |